AnPac Bio Completed 1st Half Year with Increased ASP and Revenue
SAN JOSE, Calif., July 13, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) […]
Synchronoss Technologies, Inc. Announces Date of Second Quarter Conference Call
BRIDGEWATER, N.J., July 13, 2020 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator in cloud, […]
Syneos Health Signs New Service Agreement With Pfizer
MORRISVILLE, N.C., July 13, 2020 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced […]
Celsion Corporation Receives Recommendation from Independent Data Monitoring Committee to Consider Stopping the Phase III OPTIMA Study
Recommendation Based on DMC’s Finding Following the Second Pre-Planned Interim Analysis that the OPTIMA Study is Unlikely to Meet its […]
Phathom Pharmaceuticals Announces Appointment of Todd Branning as Chief Financial Officer
FLORHAM PARK, N.J., July 13, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on […]
Kearny Financial Corp. Completes Acquisition of MSB Financial Corp.
FAIRFIELD, N.J., July 13, 2020 (GLOBE NEWSWIRE) — Kearny Financial Corp. (Nasdaq: KRNY) (“Kearny”), the holding company for Kearny Bank, […]
Bellerophon Therapeutics Announces First Patient Treated in Phase 3 Clinical Study of INOpulse® Inhaled Nitric Oxide Therapy for COVID-19
WARREN, N.J., July 13, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing […]
Kandi Affiliate Fengsheng Automotive Announces Release of Maple 30X “City SUV”
JINHUA, CHINA, July 13, 2020 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (the “Company,” “we” or “Kandi”) (NASDAQ GS: KNDI), […]
TRACON Pharmaceuticals to Host Key Opinion Leader Webinar on Envafolimab for the Treatment of Sarcoma
SAN DIEGO, July 13, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the […]
ASLAN Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
SINGAPORE, July 13, 2020 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing […]
